Research article · 14 Jul 2023
EditorialPublished 30 Jan 2022
Aspects of Spectroscopy Bioanalysis Procedures on a Technical Level
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Introduction This Policy Document focuses on the technical aspects of using inductively coupled plasma (ICP) techniques to measure pharmaceutically produced inorganic elements in bio matrices in support of GLP nonclinical and clinical research. ICP has been utilized in support of Environmental Protection Agency analyses for decades, and it has only lately been introduced to the pharmaceutical business. Current bioanalytical method validation and sample analysis regulatory advice applies to chromatographic platforms used for PK and TK analyses of big and small molecules, however it does not apply to all features of various ICP approaches. Inorganic elements in pharmaceutical substances and bio matrices are increasingly being quantified using quadrupole and high-resolution ICP–MS methods of investigation. Many endogenous elements occur in biometrics, impacting the estimation of blanks and standard deviation curve samples, QC samples, and selecting suitable levels for the LLOQ are all part of the process [1]. This White Paper describes and analyses the use of elemental bioanalytical inductively coupled plasma (ICP) techniques for quantifying pharmaceutically generated elements in biological matrices. Here are some guidelines for ICP best practices, as well as comparisons to mainstream chromatographic and immunochemical bioanalysis. Definitions are also supplied for use in ICP bioanalysis applications in nonclinical and clinical studies. Optional acceptability criteria for ICP techniques in method validation and sample analysis for endogenous elemental analyses will be discussed in this study [2]. We anticipate that the first discussion given by this White Paper will contribute in the development of scientifically sound best practices for ICP techniques used in nonclinical and clinical research. Flame and carbon furnace atomic absorption spectroscopy, ICP– MS, ICP–optical emission spectrometry (ICP–OES; also known as ICP–atomic emission spectrometry [ICP–AES]), and ICP–MS/MS have all been used for element analysis. ICP–MS, ICP–OES, and ICP–MS/MS are sensitive instruments with large linear calibration ranges that allow for simultaneous multi-element measurement. ICP Guidelines Typical chromatographic platforms used for pharmacokinetic (PK) and toxic kinetic (TK) assessments for nonclinical and clinical investigations under GLP predicate guidelines are the subject of current bioanalytical technique validation and sample analysis regulatory guidance and industry viewpoint publications. The majority of these guidelines apply to ICPbased analysis; however, there are a few exceptions that must be taken into mind. There have been only sporadic attempts to synchronise the strategy for these unique considerations [3]. For numerous reasons, the present guideline documents are not immediately applicable to all elements of ICP bioanalytical procedures.
Subjects
ChemistryMore from this journal
The newest in Physical Chemistry : An Indian Journal.
Research article · 30 Apr 2023
Physical Properties and Phase Solubility Studies of Sulfadiazine Schiff Bases Inclusion Complexes with β-Cyclodextrine
Research article · 25 Apr 2023
Adsorption Kinetics and Isotherms Studies of Acid Azo Dye based on Anthranilic Acid and Β-Naphthol on Jute Fabric
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalPhysical Chemistry : An Indian Journal
- SubjectChemistry
- BylineArticles whose byline prints “Ellie Wong”

